Ligase Targeting Drug Development Summit - May 2021 - Digital Event

Kongressthemen
As the therapeutic value of manipulating previously hard-to-drug ubiquitin ligases becomes more and more evident in addressing numerous diseases with unmet clinical needs, the inaugural Ligase Targeting Drug Development Summit arrives as the dedicated scientific and networking forum for large pharma, innovative biotech and research institutes to seize the day.

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
Speakers: Chris De Savi Vice President Head of Drug Discovery Kymera, Miklos Bekes Senior Research Investigator and Group Leader in Platform Biology Arvinas, Daniel Nomura Professor of Chemistry, University of California Berkeley and more.

https://go.evvnt.com/717315-2?pid=4832

Herr Customer Service